Screening for Drugs of Abuse (II): Cannabinoids,Lysergic Acid Diethylamide,Buprenorphine,Methadone,Barbiturates,Benzodiazepines and other Drugs

Alvarez FJ Del Rio MC . Drugs and driving. Lancet 1994; 344: 282

Brookoff D Cook CS Williams C Mann CS . Testing reckless drivers for cocaine and marijuana. N Engl J Med 1994; 331: 518–22

Taylor JF . A Road-Traffic Act (RTA) drug screening system—a survey of results. In: Oliver JS , ed. Forensic Toxicology—Proceedings of the European Meeting of the International Association of Forensic Toxicologists. London: Croom Helm, 1980

Moore FML Jarvie DR Simpson D . Urinary amphetamines, benzodiazepines and methadone: Cost-effective detection procedures. Med Lab Sci 1992; 49: 27–33

Colbert DL Gooch JC . An in-house opiate enzymoimmunoassay based on the Syva EMIT principle. Clin Chem 1992; 38: 1483–5

Ammann H Vinet B . Accuracy, precision, and interferences of three modified EMIT procedures for determining serum phenobarbital, urine morphine and urine cocaine metabolite with a Cobas Fara. Clin Chem 1991; 37: 2139–40

Boeckx RL . User modification of commercial immunoassay kits. Clin Chem 1992; 38: 1402–3

Cody JT Schwarzhoff R . Interpretation of methamphetamine and amphetamine enantiomer data. J Anal Toxicol 1993; 17: 321–5

Tetlow VA Merrill J . Rapid determination of amphetamine stereoisomer ratios in urine by gas chromatography-mass spectrometry. Ann Clin Biochem 1996; 33: 50–4

Wolff K Sanderson M Hay AWM Raistrick D . Methadone concentrations in plasma and their relationship to drug dosage. Clin Chem 1991; 37: 205–9

Bailey DN . Drug screening in an unconventional matrix: Hair analysis. JAMA 1989; 262: 3331

Cone EJ Hillsgrove MJ Jenkins AJ Keenan RM Darwin WD . Sweat testing for heroin, cocaine and metabolites. J Anal Toxicol 1994; 18: 298–305

Burns M Baselt RC . Monitoring drug use with a sweat patch: An experiment with cocaine. J Anal Toxicol 1995; 19: 41–8

Braithwaite RA Jarvie DR Minty PSB Simpson D Widdop B . Screening for drugs of abuse (I): Opiates, amphetamines and cocaine. Ann Clin Biochem 1995; 32: 123–53

Huestis MA Henningfield JE Cone EJ . Blood cannabinoids. I. Adsorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 1992; 16: 276–82

Johansson E Noren K Sjovall J Halldin MM . Determination of Δ¹ tetrahydrocannabinol in human fat biopsies from marijuana users by gas chromatography-mass spectrometry. Biomed Chromatogr 1989; 3: 35–8

Hunt CA Jones RT . Tolerance and disposition of tetrahydrocannabinol in man. J Pharmacol Exp Ther 1980; 215: 35–44

Wall ME Perez-Reyes M . The metabolism of delta-9-tetrahydrocannabinol and related cannabinoids in man. J Clin Pharamcol 1981; 21: 178S–89S

Johansson E Halldin MM . Urinary excretion half-life of Δ¹ tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking. J Anal Toxicol 1989; 13: 218–23

Ellis GM Mann MA Judson BA Schram NT Tashian A . Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin Pharmacol Ther 1985; 38: 572–8

Kanter SL Hollister LE . Marijuana metabolites in urine of man. Res Comm Chem Pathol Pharmacol 1977; 17: 421–31

Wall ME Sadler BM Brine D . Metabolism, distribution, and kinetics of delta-9-tetrahydrocan-nabinol in men and women. Clin Pharmacol Ther 1983; 34: 352–63

Stevens HM . Colour tests. In: Moffat AC Jackson JV Moss MS Widdop B , eds. Clarke's Isolation and Identification of Drugs, 2nd Edition. London: The Pharmaceutical Press, 1986: 133

Cook CE . Critical overview of immunological and chromatographic analytical methods. In: Segura J De la Torre R , eds. Current Issues of Drug Testing. Boca Raton, FL: CRC Press, 1992: 73–82

Allen LV Stiles ML . Specificity of the cannabinoid metabolite and phencyclidine EMIT d.a.u. assays. J Anal Toxicol 1988; 12: 45–7

McBay AJ . Drug analysis technology; pitfalls and problems of drug testing. In: Deutsch DG ed. Analytical Aspects of Drug Testing. New York: John Wiley, 1989: 273–93

Fraser AD Meatherall R . Lack of interference by nabilone in the EMIT d.a.u. cannabinoid assay, Abbott TDx cannabinoid assay, and a sensitive TLC assay for Δ⁹-THC carboxylic acid. J Anal Toxicol 1989; 13: 240

Berkabile DR Meyers A . False negative rate for EMIT cannabinoids. J Anal Toxicol 1989; 13: 63

Joern WA . Further observations: False negative EMIT cannabinoids. J Anal Toxicol 1989; 13: 126

Lehrer M Meenan GM . More on the false negative rate for EMIT cannabinoids. J Anal Toxicol 1990; 14: 62

Sreenivasam RC Sneath CT Jain NC . Evaluation of Emit II reagents on the Chem 1. J Anal Toxicol 1993; 17: 370–3

Green DT Armbruster DA . Screening for drugs of abuse using the Abbott ADx. Clin Chem 1990; 21: 105–8

ElSohly MA Jones AB ElSohly HN . Cross-reactivity of selected compounds in the Abbott TDx cannabinoid assay. J Anal Toxicol 1990; 14: 277–9

Karlsson L Strom M . Laboratory evaluation of the TDx assay for detection of cannabinoids in urine from prison inmates. J Anal Toxicol 1988; 12: 319–21

Schwartz RH Hawks RL . Laboratory detection of marijuana use. JAMA 1985; 254: 788–92

Pearson SD Ash KO Urry FM . Mechanism of false-negative urine cannabinoid immunoassay. Clin Chem 1989; 36: 636–8

Mikkelsen S Ash KO . Adulterants causing false negatives in illicit drug testing. Clin Chem 1988; 34: 2333–6

Warner A . Interference of common household chemicals in immunoassay methods for drugs of abuse. Clin Chem 1989; 33: 648–51

Cody JT Schwarzhoff RH . Impact of adulterants on RIA analysis of urine for drug abuse. J Anal Toxicol 1989; 13: 277–84

Kanter SL Hollister LE Musumeci M . Marijuana metabolites in urine of man. X. Identification of marijuana use by detection of Δ⁹-tetrahydrocannabinol-11-oic acid using thin layer chromatography. J Chromatogr 1982; 234: 201–8

Kaistha KK Tadrus R . Semi-quantitative mass screening detection of 11-nor-Δ⁹-tetrahydrocannabinol-9-carboxylic acid in human urine. J Chromatogr 1982; 237: 528–33

Kogen MJ Newman E Wilson NJ . Detection of marijuana metabolite 11-nor-Δ⁹-tetrahydrocannabinol in human urine by bonded phase absorption and thin layer chromatography. J Chromatogr 1984; 306: 441–3

Vinson JA Lopatofsky DJ . A semi automatic extraction and spotting system for drug analysis by TLC I. Procedure for analysis of the major metabolite of Δ⁹-tetrahydrocannabinol in urine. J Anal Toxicol 1985; 9: 6–9

Sutheimer CA Yarborough R Sunshine I . Detection and confirmation of urinary cannabinoids. J Anal Toxicol 1985; 9: 156–60

Meatherall RC Garriott JC . A sensitive thin-layer chromatographic procedure for the detection of urinary 11-nor-Δ⁹-tetrahydrocannabinol-9-carboxylic acid. J Anal Toxicol 1988; 12: 136–40

Hawks RL Chiang CN . Examples of specific drug assays. In: Hawks RL Chiang CN , eds. Urine Testing for Drugs of Abuse, NIDA Research Monograph N73. Washington DC: US Government Print Office, 1986: 84–92

Bourquin D Brenneisen R . Confirmation of cannabis abuse by the determination of 11-nor-Δ⁹-tetrahydrocannabinol-9-carboxylic acid in urine with high-performance liquid chromatography and electrochemical detection. J Chromatogr 1987; 414: 187–91

Nakahara Y Sekine H Cook CE . Confirmation of cannabis use. II. Determination of tetrahydrocannabinol metabolites in urine and plasma by HPLC with ECD. J Anal Toxicol 1989; 13: 22–4

Posey BL Kimble SN . Quantitative determination of 11-nor-Δ⁹-THC-9-COOH in urine by HPLC. J Anal Toxicol 1984; 8: 234–8

ElSohly MA ElSohly HN Jones AB Dimson PA Wells KE . Analysis of the major metabolite of THC in urine. An HPLC procedure. J Anal Toxicol 1983; 7: 262–4

Karlsson L Roos C . Combination of liquid chromatography with UV detection and GC with electron capture detection for the determination of THC-9-COOH in urine. J Chromatogr 1984; 306: 183–9

ElSohly MA Arafat ES Jones AB . Analysis of the major metabolite of THC in urine. III. AGC/ECD procedure. J Anal Toxicol 1984; 8: 7–9

McCallum NK Shaw SM . Chromatographic analysis for Δ¹-tetrahydrocannabinol in blood and brain. J Anal Toxicol 1981; 5: 148–9

Whiting JD Manders WW . Confirmation of a tetrahydrocannabinol metabolite in urine by gas chromatography. J Anal Toxicol 1982; 6: 49–52

Ritchie LK Caplan YH Park J . Δ⁹-Tetrahydrocannabinol analysis in forensic blood specimens using capillary column gas chromatography with nitrogen sensitive detection. J Anal Toxicol 1987; 11: 205–9

Willette RE . Techniques of reliable drug testing. In: Coombs RH West LJ , eds. Drug Testing: Issues and Options. New York: Oxford University Press, 1991

Federal Register, 1988, Nov 21; 53 (224)

Mule SJ Casella GA . Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening. J Anal Toxicol 1988; 12: 102–7

Schep RA , Precision and accuracy in the quantitation of carboxytetrahydrocannabinol by isotope dilution gas chromatography/mass spectrometry. J Anal Toxicol 1990; 14: 296–300

Wimbush GH Johnson KG . Full spectral GC/MS identification of Δ⁹-carboxy-tetrahydrocannabinol in urine with the Finnigan ITS-40. J Anal Toxicol 1990; 14: 292–5

Parry RC Nolan L Shirey RE Wachob GD Gisch DJ . Pre-treatment of urine samples for the analysis of 11-nor-Δ⁹-tetrahydrocannabinol-9-car-boxylic acid using solid phase extraction. J Anal Toxicol 1990; 14: 39–44

Baker TS Harry JV Russell JW Myers RL . Rapid methods for GC/MS confirmation of 11-nor-9-carboxyl-Δ⁹-tetrahydrocannabinol in urine. J Anal Toxicol 1984; 8: 255–9

Karlsson L Jonsson J Aberg K Roos C . Determination of Δ⁹-tetrahydrocannabinol-11-oic acid in urine as its pentafluoropropionyl derivative by GC/MS utilizing negative chemical ionization. J Anal Toxicol 1983; 7: 198–202

McBurney L Bobbie B Sepp L . GC/MS and EMIT analysis for Δ⁹-tetrahydrocannabinol metabolites in plasma and urine of human subjects. J Anal Toxicol 1986; 10: 56–64

Foltz R McGinnis K Chinn D . Quantitative measurement of Δ⁹-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography and negative chemical ionization mass spectrometry. Biomed Mass Spectr 1983; 10: 316–23

Clouette R Jacob M Koteel P Spain M . Confirmation of 11-nor-Δ⁹-tetrahydrocannabinol in urine as its t-butyldimethylsilyl derivative using GC/MS. J Anal Toxicol 1993; 17: 1–4

Joern WA . GC/MS assay of the marijuana carboxy metabolite: Urine interference with the dimethyl derivative. J Anal Toxicol 1992; 16: 207

Brunk SD . False negative GC/MS assay for carboxy THC due to ibuprofen interference. J Anal Toxicol 1988; 12: 290–1

Foltz RL . Analysis of cannabinoids in physiological specimens by gas chromatography/mass spectrometry. In: Baselt RC , ed. Advances in Analytical Toxicology, Vol 1. Foster City, California: Biomedical Publications, 1984

Joern WA . Surface adsorption of the urinary marijuana carboxy metabolite: The problem and the partial solution. J Anal Toxicol 1992; 16: 401

Peat MA . THCA calibrators and controls. J Anal Toxicol 1988; 12: 239

Chiang CW Barnett G . Marijuana effect and delta-9-tetrahydrocannabinol plasma level. Clin Pharmacol Ther 1984; 36: 234–8

Johansson E Halldin MM . Urinary excretion half-life of Δ¹-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking. J Anal Toxicol 1989; 13; 218–23

Cone EJ Johnson RE Paul BD . Marijuana-laced brownies; behavioural effects, physiological effects, and urinalysis following ingestion. J Anal Toxicol 1988; 12: 169–75

Johansson E Gillespie HK Halldin MM . Human urinary excretion profile after smoking and oral administration of [¹⁴C]-Δ¹-tetrahydrocannabinol. J Anal Toxicol 1990; 14: 176–80

Kelly P Jones RT . Metabolism of tetrahydrocannabinol in frequent and infrequent users. J Anal Toxicol 1992; 16: 228–35

Cone EJ Johnson RE . Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. Clin Pharmacol Ther 1986; 40: 247–56

Cone EJ Johnson RE Drawin WD Yousefnejad LD Mell BD Mitchell J . Passive inhalation of marijuana smoke; urinalysis and room air levels of Δ⁹-tetrahydrocannabinol. J Anal Toxicol 1987; 11: 89–96

Perez-Reyes M DiGuiseppi S Mason AP Davis KH . Passive inhalation of marijuana smoke and urinary secretion of cannabinoids. Clin Pharmacol Ther 1983; 32: 36–41

Mule SJ Lomax P Gross SJ . Active and realistic passive marijuana exposure tested by three immunoassays and GC/MS in urine. J Anal Toxicol 1988; 12: 113–6

Morland J Bugge A Skuterud B . Cannabinoids in blood and urine after passive inhalation of cannabis smoke. J Forensic Sci 1985; 30: 997–1002

Wright JD Pearl L . Knowledge and experience of young people regarding drug misuse 1969–94. BMJ 1995; 310: 20–4

Watson ID Tames FJ Borland W Smith B . Unequivocal epidemiology of substance abuse in cities in the U.K. Ther Drug Monit 1993; 15: 175

Greenwood J . Lothian's Community Drug Problem Service—A Five Year Review 1988–1993. Edinburgh: Community Drug Problem Service, Lothian Health Board, 1994

Lim HK Andrenyak D Francom P Foltz RL Jones RT . Quantification of LSD and N-demethyl LSD in gas chromatography—resonance electron capture ionization mass spectrometry. Anal Chem 1988; 60: 1420–5

Nelson CC Foltz RL . Chromatographic and mass spectrometric methods for determination of lysergic acid diethylamide (LSD) and metabolites in body fluids. J Chromatogr 1992; 580: 97–109

Papac DI Foltz RL . Measurement of lysergic acid diethylamide (LSD) in human plasma by gas chromatography/negative ion chemical ionisation mass spectrometry. J Anal Toxicol 1990; 14: 189–90

Ratcliffe WA Fletcher SM Moffat AC Ratcliffe JG Harland WA Levitt TE . Radioimmunoassay for lysergic acid diethylamide (LSD) in serum and urine by using antisera of different specifities. Clin Chem 1977; 23: 169–74

Stead AH Watson J Goddard CP Patel AC Moffat AC . The development and evaluation of a ¹²⁵I radioimmunoassay for the measurement of LSD in body fluids. Forensic Sci Int 1986; 32: 49–60

McCarron MM Walberg CB Baselt RC . Confirmation of LSD intoxication by analysis of serum and urine. J Anal Toxicol 1990; 14: 165–7

McNally AJ Goe-Szkutnicka K Li Z Pilcher I Polakowski S Salamone SJ . An OnLine immunoassay for LSD: Comparison with GC-MS and the Abuscreen® RIA. J Anal Toxicol 1996; 20: 404–8

Cassells NP Craston DH Hand CW Baldwin D . Development and validation of a nonisotopic immunoassay for the detection of LSD in human urine. J Anal Toxicol 1996; 20: 409–15

Lillsunde P Korte T . Comprehensive drug screening in urine using solid-phase extraction and combined TLC and GC/MS identification. J Anal Toxicol 1991; 15: 71–81

Blum LM Carenzo EF Rieders F . Determination of lysergic acid diethylamide (LSD) in urine by instrumental high-performance thin-layer chromatography. J Anal Toxicol 1990; 14: 285–7

Francom P Andrenyak D Lim H-K Bridges RR Foltz RL . Determination of LSD in urine by capillary column gas chromatography and electron impact mass spectrometry. J Anal Toxicol 1988; 12: 1–8

Rule GS Henion JD . Determination of drugs from urine by on-line immunoaffinity chromatography—high performance liquid chromatography mass spectrometry. J Chromatogr 1992; 582: 103–12

Grob K Jr Grob G Grob K . Comprehensive standardized quality test for glass capillary columns. J Chromatogr 1978; 156: 1–20

Paul BD Mitchell JM Burbage R Moy M Sroka R . Gas chromatographic-electron-impact mass fragmentographic determination of lysergic acid diethylamide in urine. J Chromatogr 1990; 529: 103–12

Nelson CC Foltz RL . Determination of lysergic acid diethylamide (LSD), iso-LSD and N-demethyl LSD in body fluids by gas chromatography/tandem mass spectrometry. Anal Chem 1992; 64: 1578–85

Peel HW Boynton AL . Analysis of LSD in urine using radio-immunoassay—excretion and storage effects. Can Soc Forensic Sci J 1980; 13: 23–8

Jaffe JH Martin WR . Opioid analgesics and antagonists. In: Gilman AG Rall TW Nies AS Taylor P , eds. Goodman and Oilman's The Pharmacological Basis of Therapeutics, Eighth Edn. New York: Pergamon Press, 1990: 485–521

Cone EJ Gorodietzky CW Yousefnejad C Buchwald WF Johnson RE . The metabolism and excretion of buprenorphine in humans. Drug Metah Dispos Biol Fate Chem 1984; 12: 577–81

Hackett LP Dusci LJ Ilett KF . Sensitive screening method for buprenorphine in urine. J Chromatogr 1986; 374: 400–4

Strang J . Abuse of buprenorphine [Letter]. Lancet 1985; ii: 725

Strang J . Abuse of buprenorphine (Temgesic) by snorting [Letter]. BMJ 1991; 302: 969

Quigley AJ Bredemeyer DE Seow SS . A case of buprenorphine abuse. Med J Aust 1984; 140: 425–6

Robertson JR Bucknall ABV . Buprenorphine: Dangerous drug or over-looked therapy? [Letter]. BMJ 1986; 292: 1465

O'Conner JJ Maloney E Travers R Campbell A . Buprenorphine abuse among opiate addicts. Br J Addict 1988; 83: 1085–7

Chowbury AN Chowbury S . Buprenorphine abuse: Report from India. Br J Addict 1990; 85: 1349–50

Haw S . Pharmaceutical Drugs and Illicit Drug Use in Lothian Region. Edinburgh: Centre for HIV/ AIDS and Drug Studies, 1993

Bullingham RES McQuay HJ Moore RA . Clinical pharmacokinetics of narcotic agonist-antagonist drugs. Clin Pharmacokinet 1983; 8: 332–43

Moore RA Hand CW . Opiate Metabolism and Excretion. Witney, UK: Diagnostic Products Corporation, 1988

Blom Y Bondesson U Anggard E . Analysis of buprenorphine and its N-dealkylated metabolite in plasma and urine by selected-ion monitoring. J Chromatogr 1985; 388: 89–98

Tebbett IR . Analysis of buprenorphine by high-performance liquid chromatography. J Chromatogr 1985; 347: 411–3

Noda J Kojima T . Quantitative determination of buprenorphine in human plasma by high-performance liquid chromatography. Hiroshima J Med Sci 1985; 34: 261–5

Debrabandere L Van Boven M Daenens P . Analysis of buprenorphine in urine specimens. J Forensic Sci 1991; 37: 82–9

Bartlett AJ Lloyd-Jones JG Ranee MJ Flock-Hart IR Dochray GJ Bennett MRD . The radioimmunoassay of buprenorphine. Eur J Clin Pharmacol 1980; 18: 339–45

Hand CW Baldwin D Moore RA Allen MC McQuay HJ . Radioimmunoassay of buprenorphine with iodine label: Analysis of buprenorphine and metabolites in human plasma. Ann Clin Biochem 1986; 23: 47–53

Diagnostic Products Corporation. Buprenorphine Double Antibody in Urine. Los Angeles: Diagnostic Products Corporation, 1989

Hand CW Ryan KE Dutt SK . Radioimmunoassay of buprenorphine in urine: Studies in patients and in a drug clinic. J Anal Toxicol 1989; 13: 100–4

Simpson D Greenwood J Jarvie DR Moore FML . Experience of a laboratory service for drug screening in urine. Scott Med J 1993; 38: 20–6

Watson ID . Analysis of commonly abused drugs at selected threshold (cutoff) concentrations. Clin Chem 1992; 38: 441

Debrabandere L Van Boven M Daenens P . Development of a radioimmunoassay for the determination of buprenorphine in biological samples. Analyst 1993; 118: 137–43

Bedford KR . Analysis for a forensic science service. In: Gough TA , ed. The Analysis of Drugs of Abuse. Chichester: John Wiley 1991: 467–8

Kintz P . Determination of buprenorphine and its dealkylated metabolite in hair. J Anal Toxicol 1993; 17: 443–4

Dole MJ Nyswander ME Kreek MJ . Narcotic blockade. Arch Int Med 1966; 118: 304–9

Dole VP Nyswander ME . Heroin addiction—a metabolic disease. Arch Int Med 1967; 120: 19–24

Goldstein A . Heroin addiction: Neurobiology, pharmacology and policy. J Psychoactive Drugs 1991; 23: 123–33

Kreck MJ . Rationale of maintenance pharmacotherapy of opiate dependence. In: O'Brian CP Jaffe JH , eds. Addictive States. New York: Raven Press, 1992: 205–30

Newman RG . Methadone treatment-defining and evaluating success. N Engl J Med 1987; 317: 447–50

Zweben JE Payte JT . Methadone maintenance in the treatment of opioid dependence: A current perspective. West J Med 1990; 152: 588–99

Condelli WS Dunteman GH . Exposure to methadone programs and heroin use. Am J Drug Alcohol Abuse 1993; 19: 65–78

Novick DM Richman BL Friedman JM Friedman JE Fried C Wilson JP . The medical status of methadone maintenance patients in treatment for 11–18 years. Drug Alcohol Depend 1993; 33: 235–45

Caplehorn JRM . A comparison of abstinence-oriented and indefinite methadone maintenance treatment. Int J Addict 1994; 29: 1361–75

Newman RG . Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet 1979; ii: 485–92

Caplehorn JR Bell J Kleinbaum DG Gebski VJ . Methadone dose and heroin use during maintenance treatment. Addiction 1993; 88: 119–24

Farrell M Ward J Mattick R Hall W Stimson GV des Jarlais D . Methadone maintenance treatment in opiate dependence: A review. BMJ 1994; 309: 997–1001

Maremmani I Nardini R Zolesi O Castrogiovanni P . Methadone dosages and therapeutic compliance during a methadone maintenance program. Drug Alcohol Depend 1994; 34: 163–6

Newman RG . Another wall that crumbled—methadone maintenance treatment in Germany. Amer J Drug Alcohol Abuse 1995; 21: 27–35

Drummer OH Syrjanen M Opeskin K Cordner S . Deaths of heroin addicts starting on a methadone maintenance programme. Lancet 1990; 335: 108

Harding-Pink D . Les deces associes a la methadone. J Toxicol Clin Exp 1991; ii: 31–49

Harding-Pink D . Methadone: One person's maintenance dose is another's poison. Lancet 1993; 341: 665–6

Worm K Steentoft A Kringsholm B . Methadone in drug addicts. Int J Legal Med 1993; 106: 119–23

Marks J . Deaths from methadone and heroin. Lancet 1994; 343: 976

Inturrisi CE Verebely K . Disposition of methadone in man after a single oral dose. Clin Pharmacol Ther 1972; 13: 923–30

Nilsson M-I Widerlov E Meresaar U Anggard E . Effect of urinary pH on the disposition of methadone in man. Eur J Clin Pharmacol 1982; 22: 337–42

Sawe J . High dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokinet 1986; 11: 87–106

Pohland A Boaz HE Sullivan HR . Synthesis and identification of metabolites resulting from the biotransformation of DL-methadone in man and in the rat. J Med Chem 1971; 14: 194–7

Garrett ER Derendorf H Mathha AG . Pharmacokinetics of morphine and its surrogates VII: High performance liquid chromatographic analysis and pharmacokinetics of methadone and its derived metabolites in dogs. J Pharm Sci 1985; 74: 1203–14

Baselt RC Cravey RH . Methadone. In: Disposition of Toxic Drugs and Chemicals in Man, 4th Edn. Foster City, California: Chemical Toxicology Institute, 1995: 472–4

Inturrisi CE Verebely K . The levels of methadone in the plasma in methadone maintenance. Clin Pharmacol Ther 1972 13: 633–7

Inturrisi EC Colburn WA Kaiko RF Houde RW Foley M . Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther 1987; 41: 392–401

Wolff K Hay AWM Raistrick D Calvert R , Steady-state pharmacokinetics of methadone in opioid addicts. Eur J Clin Pharmacol 1993; 44: 189–94

Baselt RC Casarett LJ . Urinary excretion of methadone in man. Clin Pharmacol Ther 1972; 13: 64–70

Bellward GD Warren PM Howald W Axelson JE Abbott FS . Methadone maintenance: Effect of urinary pH on renal clearance in chronic high and low doses. Clin Pharmacol Ther 1977; 22: 92–9

Saxon AJ Calsyn DA Haver VM Erickson L . A nationwide survey of urinalysis practices of methadone maintenance clinics. Arch Pathol Lab Med 1990; 114: 94–100

Holmstrand J Anggard E Gunne L-M . Methadone maintenance: Plasma levels and therapeutic outcome, Clin Pharmacol Ther 1978; 23: 176–80

Bell J Seres V Bowron P Lewis J Batey R . The use of serum methadone levels in patients receiving methadone maintenance. Clin Pharmacol Ther 1988; 43: 623–9

Wolff K Hay A Raistrick D Calvert R Feely M . Measuring compliance in methadone maintenance patients: Use of a pharmacologic indicator to “estimate” methadone plasma levels. Clin Pharmacol Ther 1991; 50: 199–207

Wolff K Hay A Raistrick D . High dose methadone and the need for drug measurements in plasma. Clin Chem 1991; 37: 1651–64

Jarvie DR Simpson D . Drug screening: Evaluation of the Toxi-lab TLC system. Ann Clin Biochem 1986; 23: 76–84

Berry DJ Grove J . Improved chromatographic techniques and their interpretation for the screening of urine from drug dependent subjects. J Chromatogr 1971; 61: 111–23

Ho IK Loh HH Way EL . Mini thin-layer chromatography in the detection of narcotics in urine from subjects on a methadone maintenance program. J Chromatogr 1972; 65: 577–9

Jain NC Leung WJ Budd RD Sneath TC . Thin-layer chromatographic separation of methadone and its primary metabolite in the presence of other drugs in urine specimens. J Chromatogr 1975; 103: 85–90

Wolff K Sanderson MJ Hay AWM . A rapid horizontal TLC method for detecting drugs of abuse. Ann Clin Biochem 1990; 27: 482–8

Simpson D Jarvie DR Heyworth R . An evaluation of six methods for the detection of drugs of abuse in urine. Ann Clin Biochem 1989; 26: 172–81

Wolff K Sanderson MJ Hay AWM Barnes I . An evaluation of the measurement of drugs of abuse by commercial and in-house horizontal thin-layer chromatography. Ann Clin Biochem 1993; 30: 163–8

Sullivan HR Blake DA . Quantitative determination of methadone concentrations in human blood, plasma and urine by gas chromatography. Res Commun Chem Pathol Pharmacol 1972; 3: 467–8

Thompson BC Caplan YH . A gas chromatographic method for the determination of methadone and its metabolites in biological fluids and tissues. J Anal Toxicol 1977; 1: 66–9

Lynn RK Leger RM Gordon WP Olsen GD Gerber N . New gas chromatographic assay for the quantification of methadone. J Chromatogr 1977; 131: 329–40

Schmidt N Sittl R Brune K Geisslinger G . Rapid determination of methadone in plasma, cerebrospinal fluid, and urine by gas chromatography and its application to routine drug monitoring. Pharm Res 1993; 40: 441–4

Caldwell R Challenger H . A capillary column gas-chromatographic method for the identification of drugs of abuse in urine samples. Ann Clin Biochem 1989; 26: 430–43

George S Braithwaite RA . A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening. Addiction 1995; 90: 227–32

Derendorf H Garrett ER . High performance liquid chromatographic assay of methadone, phencyclidine and metabolites by post column ion-pair extraction and on-line fluorescent detection of counterion with applications. J Pharm Sci 1983; 72: 630–5

Rio J Hodnett N Bidanset JH . The determination of propoxyphene and norpropoxyphene and methadone in postmortem blood and tissues by high performance liquid chromatography. J Anal Toxicol 1987; 11: 222–4

Hausmann E Kohl B Von Boehmer H Wellhoner HH . False-positive EMIT indication of opiates and methadone in doxylamine intoxication. J Clin Chem Clin Biochem 1983; 21: 599–600

Kelner MJ . Positive diphenhydramine interference in the EMIT dau assay. Clin Chem 1984; 30: 1430

Tyler A . Barbiturates. In: Street Drugs—the Facts Explained, the Myths Exploded, London; Hodder & Stoughton, 1986: 94–111

Baker O Marsden J , eds. Drug Misuse in Britain in 1994, London: Institute for the Study of Drug Dependence, 1994: 19

Stimson G Quick A , eds. Drugs: The State of the Region. A Profile of Drug and Alcohol Problems in North West Thames Regional Health Authority 1991. London: The Centre for Research on Drugs and Health Behaviour, 1992: 37

Argyll and Clyde Health Board. Health behaviours of young people in Argyll and Clyde—1992. In Baker O Marsden J , eds. Drug Misuse in Britain 1994. London: Institute for the Study of Drug Dependence, 1994: 145

Widdop B . Pharmacokinetics of drugs of abuse. In: Drugs of Abuse—Syva Symposium, Barcelona, March 1987. Palo Alto, CA, USA: Syva Company, 1987: 17–22

Tilstone WJ Stead AH . Pharmacokinetics, metabolism and the interpretation of results. In: Clark ‘s Isolation and Identification of Drugs, 2nd Ed. London: The Pharmaceutical Press, 1986: 285–6

Robinson AE McDowall RD . The distribution of amylobarbitone. butobarbitone, pentobarbitone and quinalbarbitone and the hydroxylated metabolites in man. J Pharm Pharmacol 1979; 31: 357–65

Broughton PMG . A rapid ultraviolet spectro-photometric method for the detection, estimation and identification of barbiturates in biological material. Biochem J 1956; 63: 207–13

Ferrara SD Tedeschi L Frison G Castagna F . Solid phase extraction and HPLC-UV confirmation of drugs of abuse in urine. J Anal Toxicol 1992; 16: 217–22

Widdop B . Hospital toxicology and drug screening. In: Moffat AC Jackson JV Moss MS Widdop B , eds. Clarke's Isolation and Identification of Drugs, 2nd edn. London: The Pharmaceutical Press, 1986: 3–34

Moffat AC . Thin layer chromatography. In: Moffat AC Jackson JV Moss MS Widdop B , eds. Clarke's Isolation and Identification of Drugs, 2nd edn. London: The Pharmaceutical Press, 1986: 160–77

Liu H Delgado M Forman LJ Eggers CM Montoya JL . Simultaneous determination of carbamazepine, phenytoin, phenobarbital, primidone and their principal metabolites by high-performance liquid chromatography. J Chromatogr 1993; 616: 105–15

Hill DW Kind AJ . Reversed-phase solvent-gradient HPLC retention indexes of drugs. J Anal Toxicol 1994; 18: 233–42

Eto S Noda H Noda A . Chiral separation of barbiturates and hydantoins by reversed-phase high-performance liquid chromatography using a 25 or 50 mm short ODS cartridge column via beta-cyclodextrin inclusion complexes. J Chromalogr 1992; 579: 253–8

Drummer OH Horomidis S Kourtis S Syrjanen ML Tippett P . Capillary gas chromatographic drug screen for use in forensic toxicology. J Anal Toxicol 1994; 18: 134–8

Ehresman DJ Price SM Lakatua DJ . Screening biological samples for underivatized drugs using a splitless injection technique on fused silica capillary column gas chromatography. J Anal Toxicol 1985; 9: 55–62

Coudore F Alazard M Paire M Andraud G Lavarenne J . Rapid toxicological screening of barbiturates in plasma by wide-bore capillary gas chromatography and nitrogen-phosphorus detection. J Anal Toxicol 1993; 17: 109–13

Barbour AD . GC/MS of propylated barbiturates. J Anal Toxicol 1992; 15: 214–5

Maurer HH . Identification and differentiation of barbiturates, other sedative hypnotics and their metabolites in urine integrated in a general screening procedure using computerized gas chromatography-mass spectrometry. J Chromatogr 1990; 530: 307–26

Thormann W Meier P Marcolli C Binder F . Analysis of barbiturates in human serum and urine by capillary electrophoresis-micellar electrokinetic capillary chromatography with on-column multi-wavelength detection. J Chromatogr 1991; 545: 445–60

Busto U Bendayan R Sellers EM . Clinical pharmacokinetics of non-opiate abused drugs. Clin Pharmacokinet 1989; 16: 1–26

Ericsson HR Holmgren P Jakobsson SW Lafolie P de-Rees B . Benzodiazepine findings in autopsy material. Lakartidningen 1993; 90: 3954–7

Serfaty M Masterton G . Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry 1993; 163: 386–93

Kaa E Teige B . Drug-related deaths during the 1980s. A comparative study of drug addict deaths examined at the institutes of forensic medicine in Aarhus, Denmark and Oslo, Norway. Int J Legal Med 1993; 106: 5–9

Treubeit M Halsall HB . Isolation of clobazamorosomucoid complexes from patients' sera. Biomed Chromatogr 1992; 6: 50–2

Japp M Garthwaite K Geeson AV Osselton MD . Collection of analytical data for benzodiazepines and benzophenones. J Chromatogr 1988; 439: 317–39

Moffat AC Jackson JV Moss MS Widdop B , eds. Clarke's Isolation and Identification of Drugs, 2nd edn. London: The Pharmaceutical Press, 1986

Valentour JC Monforte JR Lorenzo B Sunshine I . Fluorimetric screening method for detecting benzodiazepines in blood and urine. Clin Chem 1975; 21: 1976–9

De Giovanni N Chiarotti M . Analysis of benzodiazepines, II. High-performance liquid chromatography-fluorescence detection after molecular rearrangement to acridinones. J Chromatogr 1988; 428: 321–9

Walash MJ Belal F Metwally ME Hefnawy MM . A selective fluorimetric method for the determination of some 1,4-benzodiazepine drugs containing a hydroxyl group at C-3. J Pharm Biomed Anal 1994; 12: 1417–23

Greenblatt DJ . Determination of desmethyldiazepam in plasma by electron-capture GLC: Application to pharmacokinetic studies of clorazepate. J Pharm Sci 1978; 67: 427–9

Kangas L . Determination of nitrazepam and its main metabolites in urine by gas-liquid chromatography: Use of electron capture and nitrogen-selective detectors. J Chromatogr 1979; 172: 273–8

Drouet-Coassolo C Aubert C Coassolo P Cano JP . Capillary gas chromatographic-mass spectrometric method for the identification and quantification of some benzodiazepines and their unconjugated metabolites in plasma. J Chromatogr 1989; 487: 295–311

Boukhabza A Lugnier AA Kintz P Mangin P . Simultaneous HPLC analysis of the hypnotic benzodiazepines nitrazepam, estazolam, flunitrazepam and triazolam in plasma. J Anal Toxicol 1991; 15: 319–22

Lillsunde P Seppala T . Simultaneous screening and quantitative analysis of benzodiazepines by dual-channel chromatography using electron-capture and nitrogen-phosphorus detection. J Chromatogr 1990; 533: 97–110

Puopolo PR Pothier ME Volpicelli SA Flood JG . Single procedure for detection, confirmation, and quantification of benzodiazepines in serum by liquid chromatography with photodiode-array detection. Clin Chem 1991; 37: 701–6

Hernandez A Gutierrez P Thomas J . Ion pairs of benzodiazepines and alkaloids with bromothymol blue and their analytical applications. Farmaco Prat 1986; 41: 300–6

Watson ID Stewart MJ . Assay of tricyclic structured drugs and their metabolites in urine by high performance liquid chromatography. J Chromatogr 1977; 134: 182–6

Van de Merbel NC Teule JM Lingeman H Brinkman UA . Dialysis as an on-line sample-pretreatment technique for column liquid chromatography: Influence of experimental variables upon the determination of benzodiazepines in human plasma. J Pharm Biomed Anal 1992; 10: 225–33

Suzuki O Seno H Kumazawa T . Rapid isolation of benzodiazepines with Sep-Pak C18 cartridges. J Forensic Sci 1988; 33: 1249–53

Mazhar M Binder SR . Analysis of benzodiazepines and tricyclic antidepressants in serum using a common solid-phase cleanup and a common mobile phase. J Chromatogr 1989; 497: 201–12

Casas M Berrueta LA Gallo B Vicente F . Solid-phase extraction of 1,4-benzodiazepines from biological fluids. J Pharm Biomed Anal 1993; 11: 277–84

Gaillard Y Gay-Montchamp JP Ollagnier M . Simultaneous screening and quantitation of alpidem, Zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection after solid-phase extraction. J Chromatogr 1993; 622: 197–208

Chen XH Franke JP Wijsbeek J De Zeeuw RA . Isolation of acidic, neutral, and basic drugs from whole blood using a single mixed mode solid-phase extraction column. J Anal Toxicol 1992; 16: 351–5

Hartvig P . Electron capture GC of drugs: studies on amine derivatives [Thesis]. Uppsala: University of Uppsala, 1974: 1–25

Schutz H Westenberger V . Gaschromatographische daten von 19 hydrolysederivaten aus 12 wichtigen benzodiazepinen und 17 hauptmetaboliten. Z Rechtsmed 1978; 82: 43–53

De la Guardia M Galdu MV Monzo J Salvador A . Simultaneous determination of benzodiazepines by ultraviolet-visible spectrophotometry in micellar media. Analyst 1989; 114: 509–12

Joern WA . Confirmation of low concentrations of urinary benzodiazepines, including alprazolam and triazolam, by GC-MS: An extractive alkylation procedure. J Anal Toxicol 1992; 16: 363–7

Weist FR . Detection of oxazepam in biological fluids by thin layer chromatography. Arzneimittelforschung 1968; 18: 87–92

Sun S . Fluorescence TLC densitometric determination of diazepam and other 1,4-benzodiazepines in serum. J Pharm Sci 1978; 67: 1413–5

Schutz H Borchert A Holland EM Schneider WR Scholermann K . Screening for tetracyclic benzo-and thienodiazepines and their metabolites with thin layer chromatography using the corrected Rf value. Beitr Gerichtl Med 1988; 46: 149–53

Sawada H Shinohara K . Detection and identification of nitrazepam and related compounds by thin-layer chromatography. Arch Toxicol 1970; 27: 71–8

Vuduc T Vernay A . Validation d'un procede de detection des benzodiazepines dans l'urine par extraction acide de leurs benzophenones et chromatographic sur couche mince. Ann Biol Chem 1985; 43: 261–5

Kovacs-Hadady K . Overpressured layer chromatographic study of retention behaviour of various benzodiazepine derivatives on layers impregnated with tricaprylmethyl ammonium chloride. J Pharm Biomed Anal 1992; 10: 1025–32

Sadee W van der Kleijn E . Thermolysis of 1,4-benzodiazepines during gas chromatography and mass spectroscopy. J Pharm Sci 1971; 60: 135–7

Greaves MS . Quantitative determination of medazepam, diazepam and nitrazepam in whole blood by flame-ionisation GLC. Clin Chem 1974; 20: 141–5

Foster LB Frings CS . Determination of diazepam (Valium) concentrations in serum by gas chromatography. Clin Chem 1970; 16: 177–9

Gjerde H Dahlin E Christophersen AS . Simultaneous determination of common benzodiazepines in blood using gas chromatography. J Pharm Biomed Anal 1992; 10: 317–22

Le Gatt DF McIntosh DP . Clobazam and norclobazam quantitation in serum by capillary gas chromatography with electron-capture detection. Clin Biochem 1993; 26: 159–63

Marliac Y Barazi S . Determination du clobazam sous sa forme inchangee dans la plasma par chromatographic gaz-liquide. Ann Pharm Fr 1989; 47: 213–20

Beharrell GP Hailey DM McLaurin MK . Determination of nitrazepam (Mogadon) in plasma by electron capture gas-liquid chromatography. J Chromatogr 1972; 70: 45–7

Ferguson JL Couri D . Electron capture gas chromatography determination of benzodiazepines and metabolites. J Anal Toxicol 1977; 1: 171–4

Wilson JM Friel PN Wilensky AJ Raisys VA . A methods comparison: Clonazepam by gas chromatography-electron capture and gas chromatography-mass spectroscopy. Ther Drug Monit 1979; 1: 387–97

De Silva JA Berkersky I Puglisi CV Brooks MA Weinfeld RE . Determination of 1,4-benzodiazepines and -diazepine-2-ones in blood by electron-capture gas chromatography. Anal Chem 1976; 48: 10–9

Berrueta LA Gallo B Vicente F . Biopharmacological data and high-performance liquid chromatographic analysis of 1,4-benzodiazepines in biological fluids: A review. J Pharm Biomed Anal 1992; 10: 109–36

Guitton J David O Mialon A Manchon M . Evaluation of an automated liquid chromatograph permitting toxicologic screening of biological fluids. Ann Biol Clin (Paris) 1993; 51: 611–7

Shimamine M Masunari T Nakahara Y . Studies on identification of drugs of abuse by diode array detection. I. Screening-test and identification of benzodiazepines by HPLC-DAD with ICOS software system. Eisei Shikenjo Hokoku 1993; 111: 47–56

Musshoff F Daldrup T . A rapid solid-phase extraction and HPLC/DAD procedure for the simultaneous determination and quantitation of different benzodiazepines in serum, blood and post-mortem blood. Int J Legal Med 1992; 105: 105–9

Macek K Rehak V . High-resolution liquid chromatography of some psychotropic drugs. J Chromatogr 1975; 105: 182–5

Tjaden UR Meeles MT Thys CP van der Kaay M . Determination of some benzodiazepines and metabolites in serum, urine and saliva by high-performance liquid chromatography. J Chromatogr 1980; 181: 227–41

McIntyre IM Syrjanen ML Crump K Horomidis S Peace AW Drummer OH . Simultaneous HPLC gradient analysis of 15 benzodiazepines and selected metabolites in postmortem blood. J Anal Toxicol 1993; 17: 202–7

Mura P Piriou A Fraillon P Papet Y Reiss D . Screening procedure for benzodiazepines in biological fluids by high-performance liquid chromatography using a rapid-scanning multichannel detector. J Chromatogr 1987; 416: 303–10

Tai HL Osiewicz RJ Bofinger DP . A salt-free isocratic high-pressure liquid chromatographic method for the quantitation of benzodiazepines in serum. Clin Biochem 1993; 26: 165–71

Demedts P Wauters A Franck F Neels H . Evaluation of the REMEDI drug profiling system. Eur J Clin Chem Clin Biochem 1994; 32: 407–17

Moore CM Sato K Katsumata Y . Rapid monitoring of benzodiazepines in clinical samples by using on-line column switching HPLC. Clin Chem 1991; 37: 804–8

Lacroix C Wojceichowski F Danger P . Monitoring of benzodiazepines (clobazam, diazepam and their main active metabolites) in human plasma by column-switching high-performance liquid chromatography. J Chromatogr 1993; 617: 285–90

Lloyd JB Parry DA . Forensic applications of the determination of benzodiazepines in blood samples by microcolumn cleanup and high-performance liquid chromatography with reductive mode electrochemical detection. J Anal Toxicol 1989; 13: 163–8

Oliveros L Minguillin C Billaud C . Resolution of several racemic 3-hydroxy-1,4-benzodiazepin-2-ones by high-performance liquid chromatography on a chiral silica-bonded stationary phase. J Pharm Biomed Anal 1992; 10: 925–30

Franzelius C Besserer K . Identification and quantitation of intact diastereosiomeric benzodiazepine glucuronides in biological samples by high-performance liquid chromatography. J Chromatogr 1993; 613: 162–7

Domenici E Bertucci C Salvadori P Wainer IW . Use of a human serum albumin-based high-performance liquid chromatography chiral stationary phase for the investigation of protein binding: Detection of the allosteric interaction between warfarin and benzodiazepine binding sites. J Pharm Sci 1991; 80: 164–6

Peat MA Kopjak K . The screening and quantitation of diazepam, flurazepam, chlordiazepoxide and their metabolites in blood and plasma by electron-capture gas chromatography and high pressure liquid chromatography. J Forensic Sci 1979; 24: 46–54

Douse JM . Trace analysis of explosives by capillary supercritical fluid chromatography with thermal energy analysis detection. J Chromatogr 1988; 445: 244–50

Schafroth M Thormann W Allemann D . Micellar electokinetic capillary chromatography of benzodiazepines in human urine. Electrophoresis 1994; 15: 72–8

Johansson IM Pavelka R Henion JD . Determination of small drug molecules by capillary electrophoresis-atmospheric pressure ionization mass spectrometry. J Chromatogr 1991; 559: 515–28

Zamecnik J Ethier JC Neville G . Benzodiazepines—an extensive review of mass spectra, Can Soc Forensic Sci J 1989; 22: 233–62

McCarley TD Brodbelt J . Structurally diagnostic ion-molecule reactions and collisionally activated dissociation of 1,4-benzodiazepines in a quadrupole ion trap mass spectrometer. Anal Chem 1993; 65: 2380–8

Song H Abramson FP . Selective detection of chlorine-containing compounds by gas chromatography/chemical reaction interface mass spectrometry. Anal Chem 1993; 65: 447–50

Maurer H Pfleger K . Identification and differentiation of benzodiazepines and their metabolites in urine by computerised gas chromatography-mass spectrometry. J Chromatogr 1987; 422: 85–101

Moore C Long G Marr M . Confirmation of benzodiazepines in urine as trimethylsilyl derivatives using gas chromatography-mass spectrometry. J Chromatogr Biomed Appl 1994; 655: 132–7

Dickson PH Markus W McKernan J Nipper HC . Urinalysis of alpha-hydroxyalprazolam, alpha-hydroxytriazolam, and other benzodiazepine compounds by GC-ELMS. J Anal Toxicol 1992; 16: 67–71

Garland WA Barbalas MP . Applications to analytic chemistry: An evaluation of stable isotopes in mass spectral drug assays. J Clin Pharmacol 1986; 26: 412–8

Fitzgerald RL Rexin DA Herold DA . Benzodiazepine analysis by negative chemical ionization gas chromatography/mass spectrometry. J Anal Toxicol 1993; 17: 342–7

Higuchi S Urabe H Shiobara Y . Simplified determination of lorazepam and oxazepam in biological fluids by gas chromatography-mass spectrometry. J Chromatogr 1979; 164: 55–61

West RE Ritz DP . GC/MS analysis of five common benzodiazepine metabolites in urine as tert-butyl-dimethylsilyl derivatives. J Anal Toxicol 1993; 17: 114–6

Jones CE Wians FH Jr Martinez LA Merritt GJ . Benzodiazepines identified by capillary gas chromatography-mass spectrometry, with specific ion screening used to detect benzophenone derivatives. Clin Chem 1989; 35: 1394–8

Mule SJ Casella GA . Quantitation and confirmation of the diazolo- and triazolobenzodiazepines in human urine by gas chromatography/ mass spectrometry. J Anal Toxicol 1989; 13: 179–84

Duthel JM Constant H Vallon JJ Rochet T Miachon S . Quantitation by gas chromatography with selected-ion monitoring mass spectrometry of “natural” diazepam, N-desmethyldiazepam and oxazepam in normal human serum. J Chromatogr 1992; 579: 85–91

Meatherall R . GC-MS confirmation of urinary benzodiazepine metabolites. J Anal Toxicol 1994; 18: 369–81

Black DA Clark GD Haver VM Garbin JA Saxon AJ . Analysis of urinary benzodiazepines using solid-phase extraction and gas chromatography-mass spectrometry. J Anal Toxicol 1994; 18: 185–8

Yoshida M Watabiki TR Tokiyasu T Saito I Ishida N . Determination of benzodiazepines by thermospray liquid chromatograph-mass spectrometer. Part 1. Nitrazepam, estazolam, bromazepam, flunitrazepam. Nippon Hoigaku Zasshi 1993; 47: 220–6

Verweiji AM Lipman PJ Zweipfenning PG . Quantitative liquid chromatography, thermospray/tandem mass spectrometry (LC/TSP/MS/ MS) analysis of some thermolabile benzodiazepines in whole blood. Forensic Sci Int 1992; 54: 67–74

Kanamori M . The development of mass-screening method for benzodiazepines by radioimmunoassay. Nippon Hoigaku Zasshi 1993; 47: 18–28

Aderjan R Schmidt G . A screening radioimmunoassay for 1,4-benzodiazepines in human blood, serum and urine using anti-oxazepam-hemisuccinate-antibodies. Z Rechtsmed 1979; 83: 191–200

Huang W Moody DE Andrenyak DM Rollins DE . Immunoassay detection of nordiazepam, triazolam, lorazepam and alprazolam in blood. J Anal Toxicol 1993; 17: 365–9

Dixon R . Radioimmunoassay of benzodiazepines. Methods Enzymol 1982; 84: 490–515

Jortani SA Poklis A . Evaluation of the Syva ETS Plus urine drug and serum ethanol analyzer. J Anal Toxicol 1993; 17: 31–3

Taylor J . Sensitivity of the EMIT d.a.u. for benzodiazepines [Letter]. J Anal Toxicol 1988; 12: 53

Gruhl H . Screening of benzo- and thienodiazepines in urine with Emit ST and thin layer chromatography within the scope of substance abuse. Z Rechtsmed 1987; 98: 221–8

Beck O Lafolie P Hjemdahl P Borg S Odelius G Wirbing P . Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: Two techniques evaluated and modified for improved performance. Clin Chem 1992; 38: 271–5

Beck O Lafolie P Odelius G Boreus LO . Immunological screening of benzodiazepines in urine: Improved detection of oxazepam intake. Toxicol Lett 1990; 52: 7–14

Asselin WM Leslie JM . Modification of Emit assay reagents for improved sensitivity and cost effectiveness in the analysis of hemolyzed whole blood. J Anal Toxicol 1992; 16: 381–8

Lewellen LJ McCurdy HH . A novel procedure for the analysis of drugs in whole blood by homogeneous enzyme immunoassay (EMIT). J Anal Toxicol 1988; 12: 260–4

Blum LM Klinger RA Rieders F . Direct automated EMIT d.a.u. analysis of N,N-dimethylformamide-modified serum, plasma and postmortem blood for benzodiazepines, benzoyl-ecgonine, cannabinoids and opiates. J Anal Toxicol 1989; 13: 285–8

Hallbach J Guder WG . Mechanised toxicological serum tests in screening hospitalized patients. Eur J Clin Chem Clin Biochem 1991; 29: 537–47

Sreenivasam RC Sneath TC Jain NC . Evaluation of EMIT II reagents on the Chem-1. J Anal Toxicol 1993; 17: 370–3

Beck O Lafolie P Hjemdahl P . Modification of commercial kits is justified [Letter]. Clin Chem 1993; 39: 1352–3

Fraser AD . Urinary screening for alprazolam, triazolam, and their metabolites with the EMIT d.a.u. benzodiazepine metabolite assay. J Anal Toxicol 1987; 11: 263–6

Schutz H Schneider WR . Screening for tetracyclic benzodiazepines using EMIT-st (benzodiazepines) and TDx. Z Rechtsmed 1987; 99: 181–9

Badcock NR Zoanetti GD . False negative results with benzodiazepine screening test [Letter]. J Clin Pathol 1989; 42: 557–8

Rollins DE Jennison TA Jones D . Investigation of interference by non-steroidal antiinflammatory drugs in urine testing for abused drugs. Clin Chem 1990; 36: 602–6

Joseph R Dickerson S Willis R Frankenfield D Cone EJ Smith DR . Interference by non-steroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse. J Anal Toxicol 1995; 19: 13–7

Perrigo BJ Joynt BP . Use of ELISA for the detection of common drugs of abuse in forensic whole blood samples. Can Soc Forensic Sci J 1995; 28: 261–9

Simonsson P Liden A Lindberg S . Effect of beta-glucuronidase on urinary benzodiazepine concentrations determined by fluorescence polarisation immunoassay. Clin Chem 1995; 41: 920–3

Fraser AD Bryan W . Evaluation of the Abbott ADx and TDx serum benzodiazepines immunoassays for analysis of alprazolam. J Anal Toxicol 1991; 15: 63–5

Becker J Correll A Koepf W Rittner C . Comparative studies on the detection of benzodiazepines in serum by means of immunoassays (FPIA). J Anal Toxicol 1993; 17: 103–8

Ensing K Bosman IJ Egberts AC Franke JP de-Zeeuw RA . Application of radioreceptor assays for systematic toxicological analysis. I. Theoretical considerations and evaluation. J Pharm Biomed Anal 1994; 12: 59–63

Bruhwyler J Hassoun A . Potential use of a radioreceptor assay for the determination of benzodiazepine compounds in serum. J Anal Toxicol 1993; 17: 403–7

Bruhwyler J Hassoun A . The use of radioreceptor assays for the determination of benzodiazepines in biological samples: A review. J Anal Toxicol 1992; 16: 244–52

Koch TR Raglin RL Kirk S Bruni JF . Improved screening for benzodiazepine metabolites in urine using the Triage Panel for Drugs of Abuse. J Anal Toxicol 1994; 18: 168–72

Rohrich J Schmidt K Bratzke H . Application of the novel immunoassay TRIAGE to a rapid detection of antemortem drug abuse. J Anal Toxicol 1994; 18: 407–14

Valentine JL Komoroski EM . Use of a visual panel detection method for drugs of abuse: Clinical and laboratory experience with children and adolescents. J Pediatr 1995; 126: 135–40

Brown ERS Jarvie DR Simpson D . Evaluation of Bionike One Step tests for the detection of drugs of abuse in urine. Ann Clin Biochem 1997; 34: 74–80

Gibb RP Cockerham H Goldfogel GA Lawson GH Raisys V . Substance abuse testing of urine by GC/MS in scanning mode evaluated by proficiency studies, TLC/GC, and EMIT. J Forensic Sci 1993; 38: 124–33

Bogusz M Aderjan R Schmitt G Nadler E Neureither B . The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays: A comparative study. Forensic Sci Int 1990; 48: 27–37

Meatherall R . Benzodiazepine screening using EMIT II and TDx: Urine hydrolysis pretreatment required. J Anal Toxicol 1994; 18: 385–90

Minder EI Schaubhut R Simmler F . Toxicological screening for benzodiazepines in urine: EMIT-ST versus high-performance liquid chromatography with photodiode array detection. Toxicol Lett 1989; 45: 93–9

Von Meyer L Kauert G Drasch G . Comparison of benzodiazepine screening using the fluorescence polarization immunoassay (Abbott TDx) and thin layer chromatography in the area of low concentrations. Beitr Gerichtl Med 1988; 46: 143–7

Edinboro LE Poklis A . Detection of benzodiazepines and tribenzazolams by TRIAGE: Confirmation by solid-phase extraction utilizing SPEC.3ML.MP3 microcolumns and GC-MS. J Anal Toxicol 1994; 18: 312–6

Nordholm L Mengel H . Determination of an oxadiazole-substituted 1,4-benzodiazepine in plasma by high-performance liquid chromatography with ultraviolet detection and by a radioreceptor assay. J Chromatogr 1989; 494: 257–65

Schutz H . Modern screening strategies in analytical toxicology with special regard to new benzodiazepines. Z Rechtsmed 1988; 100: 19–37

Fraser AD Isner AF Bryan W . Urinary screening for adinazolam and its major metabolites by the EMIT d.a.u. and FPIA benzodiazepine assays with confirmation by HPLC. J Anal Toxicol 1993; 17: 427–31

Fitzgerald RL Rexin DA Herold DA . Detecting benzodiazepines: Immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry. Clin Chem 1994; 40: 373–80

Ferrara SD Tedeschi L Frison G Castagna F Bernadelli B Soregaroli D . Drugs of abuse testing in urine: A statistical approach and experimental comparison of immunochemical and chromatographic techniques. J Anal Toxicol 1994; 18: 278–91

Baselt RC . Disposition of Toxic Drugs and Chemicals in Man, 2nd edn. Davis, California: Biomedical Publications, 1982

Wennig R . Practical Compendium for Health Professionals: Drugs of Abuse Currently Used in Europe. Luxembourg: Commission of the European Communities Directorate General Employment, Industrial Relations and Social Affairs. Health and Safety Directorate, 1992: 16–9

Verebey K Jukofsky D Mule SJ . Confirmation of EMIT benzodiazepine assay with GLC/NPD. J Anal Toxicol 1982; 6: 305–8

Needleman SB Porvaznik M . Identification of parent benzodiazepines by gas chromatography/ mass spectroscopy (GC/MS) from urinary extracts treated with beta-glucuronidase. Forensic Sci Int 1995; 73: 49–60

Gilliespie TJ Gandolfi AJ Davies TP Morano RA . Identification and quantification of alphamethylfentanyl in post mortem specimens. J Anal Toxicol 1982; 6: 139–42

Matejczyk RJ . Fentanyl related overdose. J Anal Toxicol 1988; 12: 236–8

Wennig R . Practical Compendium for Health Professionals: Drugs of Abuse Currently Used in Europe. Luxembourg: Commission of the European Communities, Directorate General Employment, Industrial Relations and Social Affairs, Health and Safety Directorate, 1992: 32

McQuay HJ Moore RA Paterson GMC Adams AP . Plasma fentanyl concentrations and clinical observations during and after operation. Br J Anaesth 1979; 51: 543–50

Hess R Stiebler G Herz A . Pharmacokinetics of fentanyl in man and the rabbit. Eur J Clin Pharmacol 1972; 4: 137–41

Schleimer R Benjamini E Eisele J Henderson G . Pharmacokinetics of fentanyl as determined by radioimmunoassay. Clin Pharmacol Ther 1978; 23: 188–94

McClain DA Hug CC . Intravenous fentanyl kinetics. Clin Pharmacol Ther 1980; 28: 106–14

Van Rooy HH Vermeulan NPE Bovill JG . The assay of fentanyl and its metabolites in plasma of patients using gas chromatography with alkali flame detection and gas chromatography-mass spectrometry. J Chromatogr 1981; 223: 85–93

Gilliespie TJ Gandolfi AJ Maiorino PM Vaughan RW . Gas chromatographic determination of fentanyl and its analogues in human plasma. J Anal Toxicol 1981; 5: 133–7

Michiels M Hendriks R Heykants J . A sensitive radioimmunoassay for fentanyl. Eur J Clin Pharmacol 1977; 12: 153–8

Alburges ME Hanson GR Gibb JW Sakashita CO Rollins DE . Fentanyl receptor assay: I. Development of a radioreceptor assay for the analysis of fentanyl and fentanyl analogs in urine. J Anal Toxicol 1991; 15: 311–8

Alburges ME Hanson GR Gibb JW Sakashita CO Rollins DE . Fentanyl receptor assay: II. Utilization of a radioreceptor assay for the analysis of fentanyl analogs in urine. J Anal Toxicol 1992; 16: 36–41

Watts VW Caplan YH . Evaluation of the Coat-A-Count ¹²⁵I fentanyl RIA: Comparison of the ¹²⁵I RIA and GC/MS-SIM for quantification of fentanyl in case urine specimens. J Anal Toxicol 1990; 14: 266–72

Ruangyuttikarn W Law MY Rollins DE Moody DE . Detection of fentanyl and its analogs by enzyme-linked immunosorbent assay. J Anal Toxicol 1990; 14: 160–4

Makowski GS Richter JJ Moore RE Eisma R Ostheimer D Onoroski M . An enzymelinked immunosorbent assay for urinary screening of fentanyl citrate abuse. Ann Clin Lab Sci 1965; 25: 169–78

Ketamine misuse identified [Editorial]. Pharm J 1992; 248: 444

Kamaya H Krishna PR . Ketamine addiction [Letter]. Anesthesiology 1987; 67: 861–2

Jansen KLR . Ketamine—can chronic use impair memory? Int J Addict 1990; 25: 133–9

Peyton SH Couch AT Bost RO . Tissue distribution of ketamine: Two case reports. J Anal Toxicol 1988; 12: 268–9

Wieber J Gugler R Hengstmann JH Dengler HJ . Pharmacokinetics of ketamine in man. Anaesthesist 1975; 24: 260–3

Pitts FN Jn. Yago LS Aniline O Pitts AF . Capillary gas chromatography with a nitrogen detector for measurement of phencyclidine, ketamine and other arylcycloalkylamines. J Chromatogr 1980; 193: 157–9

Chang T Glazko AJ . A gas chromatographic assay for ketamine in human plasma. Anesthesiology 1972; 36: 401–4

Needham LL Kochhar MM . Determination of ketamine and some in vivo metabolites using high pressure liquid chromatography. J Chromatogr 1975; 114: 220–2

Analytical Systems Inc. Ketamine: Differentiation from PCP, methaqualone and cocaine. In: Toxi-Lab Drug Compendium. Laguna Hills, CA: Analytical Systems Inc, 1983

Pentazocine. In: Moffat AC Jackson JV Moss MS Widdop B , eds. Clarke's Isolation and Identification of Drugs, 2nd edn. London: Pharmaceutical Press, 1986: 860–1

Ryall JE Stumpers AC . Pentazocine Poisoning. Bull Int Ass Forensic Toxicol 1991; 21: 31–3

Showalter CV Moore L . Abuse of pentazocine and tripelannamine [Letter]. JAMA 1978; 239: 1610–2

Poklis A Mackell MA . Pentazocine and tripelennamine (T's and Blues) abuse: Toxicological findings in 39 cases. J Anal Toxicol 1982; 6: 109–14

Agurell S Boreus LO Gordon E Lindgren JE Ehrnebo M Lonroth U . Plasma and cerebrospinal fluid concentrations of pentazocine in patients: Assay by mass fragmentography. J Phar Pharmacol 1974; 26: 1–8

Beckett AH Taylor JF Kourounakis P . The absorption, distribution and excretion of pentazocine in man after oral and intravenous administration. J Pharm Pharmacol 1970; 22: 123–8

Pittman KA . Human metabolism of orally administered pentazocine. Biochem Pharm 1970; 19: 1833–6

Analytical Systems Inc. Pentazocine. In: Toxi-Lab Drug Compendium. Laguna Hills, CA: Analytical Systems Inc, 1983

Gott PH . Cyclizine toxicity—international drug abuse of a proprietary antihistamine. N Engl J Med 1968; 279: 596

Lewin JF Missen AW Gwyn SA . A death principally due to cyclizine. Bull Int Ass Forensic Toxicol 1981; 16: 23–4

Sheehan TMT Paterson SC Clarke JGN Minty PSB . The abuse of preparations containing dipipanone and cyclizine; analytical aspects and their interpretation. In: Oliver JS , ed. Forensic Toxicology—Proceedings of the European Meeting of the International Association of Forensic Toxicologists. London: Croom Helm, 1980

Marjot DH . Hazards of diconal [Letter]. BMJ 1978; i: 1214

Wiles D Black F Tetlow VA Waterhouse J Paterson JR . Diconal abuse among clients of a substance misuse centre in South West Scotland [Abstract]. In: Martin SM Halloran SP Green AGE , eds. Proceedings of the ACB National Meeting; 1994 May 9–13; Brighton. London: Association of Clinical Biochemists, 1994: 36

Kuntzman R Klutch A Tsai I Burns JJ . Physiological distribution and metabolic inactivation of chlorcyclizine and cyclizine. J Pharmacol Exp Ther 1965; 149: 29–35

Kuntzman R Tsai I Burns JJ . Importance of tissue and plasma binding in determining the retention of norchlorcyclizine and norcyclizine in man, dog and rat. J Pharmacol Exp Ther 1967; 158: 332–9

Land G Dean K Bye A . Determination of cyclizine and norcyclizine in plasma and urine using gas-liquid chromatography with nitrogen selective detection. J Chromatogr 1981; 222: 135–40

Griffin DS Baselt RC . Blood and urine concentrations of cyclizine by nitrogen-phosphorus gas-liquid chromatography. J Anal Toxicol 1984; 8: 97–9

Schuckit MA Morrissey ER . Propoxyphene and phencyclidine (PCP) use in adolescents. J Clin Psychiatry 1978; 39: 7–13

Widdop B Caldwell R . The operation of a hospital laboratory service for the detection of drugs of abuse. In: Gough TA , ed. The Analysis of Drugs of Abuse. Chichester: John Wiley, 1991: 430–51

Syva Company. EMIT d.a.u. Propoxyphene Assay (Package insert). Palo Alto, CA: Syva Company, 1990

King JW King LJ . Propoxyphene and norpropoxyphene quantitation in the same solid-phase extraction using Toxi-Lab Spec VC MP3 system. J Anal Toxicol 1994; 18: 217–9

Kintz P Mangin P . Abbott propoxyphene assay; evaluation and comparison of TDx FPIA and GC/MS methods. J Anal Toxicol 1993; 17: 222–4

Analytical Systems Inc. Propoxyphene. In: Toxi-Lab Drug Compendium. Laguna Hills, CA: Analytical Systems Inc, 1983

Margot PA Crouch DJ Finkle BS Johnson JR Deyman ME . Capillary and packed column GC determination of propoxyphene and norpropoxyphene in biological specimens: Analytical problems and improvements. J Chromatogr Sci 1983; 21: 201–4

Kunka RL Yong C-L Ladik CF Bates TR . Liquid chromatographic determination of propoxyphene and norpropoxyphene in plasma and breast milk. J Pharm Sci 1985; 74: 103–4